course alzheimer readily available early tests improve treatment letting patients measures stay healthy affording opportunity plan uncertain future participate clinical trials preventive standpoint blood tests help identify risk mielke says testing screen potential participants experimental drugs past trials beta amyloid reducing treatments turned not brain amyloid nowadays trials require participants evidence disease pathology pet scans csf measures prescreening cheap blood test needed enroll volunteers according new study published january 22 journal lower cost trials means potential treatments tested increases chances finding cure says elisabeth thijssen researcher studying blood biomarkers alzheimer amsterdam university medical centers netherlands blood tests particularly helpful identifying